Travere Therapeutics, Inc.
TVTX
Revenue
62.90M
▲8.78M▲16.23%
3 Months ChangeAssets
504.41M
▼-46.71M▼-8.48%
3 Months ChangeLiabilities
534.86M
▼-1.11M▼-0.2071%
3 Months ChangeFree Cash Flow
-119.01M
▼-37.26M▼-45.58%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 10-Q
ID: 0001438533-24-000048
2024-10-31
Form 8-K
ID: 0001438533-24-000046
2024-09-26
Form 8-K
ID: 0001438533-24-000038
2024-09-06
Form 8-K
ID: 0001438533-24-000035
2024-08-01
Form 10-Q
ID: 0001438533-24-000031
2024-08-01
Form 8-K
ID: 0001438533-24-000030
2024-05-13
Form 8-K
ID: 0001438533-24-000022
2024-05-06
Form 10-Q
ID: 0001438533-24-000020
2024-05-06
Form 8-K
ID: 0001438533-24-000019
2024-04-24
Form 8-K
ID: 0001438533-24-000016